Navigation Links
Merial to Screen Chimerix' Chemical Library for Animal Health Drug Leads
Date:1/29/2008

DULUTH, Ga. and RESEARCH TRIANGLE PARK, N.C., Jan. 29 /PRNewswire/ -- Merial Limited and Chimerix, Inc. announced today that they have signed an agreement under which Merial will screen a Chimerix chemical library for animal health drug leads. Under the terms of this agreement, Merial has an option to negotiate a license with Chimerix for leads identified for possible animal health use.

"This collaboration with Chimerix provides us with an opportunity to further expand our ability to identify novel active compounds that will form the basis of new products designed to meet our customers' future needs," states Dr. Peter Hanson, Head of Pharmaceutical R&D.

"Collaborating with Merial, a known leader in animal health, will allow us to capitalize on active leads obtained through our chemical library for animal health indications that otherwise may not be developed," stated George Painter, President and CEO of Chimerix. "Our company is excited about the possibility of contributing to the development of a medication that will positively impact the health and well-being of animals."

About Merial

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs more than 5,000 people and operates in more than 150 countries worldwide. Its 2007 sales were nearly $2.5 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please see http://www.merial.com.

About Chimerix

Chimerix, Inc. discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a powerful lipid, prodrug technology, ProLipTag(TM), Chimerix is able to develop drug candidates with oral-availability, increased potency and targeted delivery. These enhanced pharmaceutical properties can be applied to new drug moieties or known drugs to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse events. For more information, please see http://www.chimerix-inc.com.


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
2. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
3. BioReliance Launches Next-Generation Genotoxicity Screening Service
4. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
5. Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
6. Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy
7. Dude, big screen TVs, flexible electronics and surfboards made from same new material!
8. FED-TVs with carbon nanotube technology could supersede plasma and LCD flat screens
9. Siemens Unveils New Digital Mammography System for Optimized Screening
10. International Association of Fire Fighters (IAFF) Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO-Oximetry
11. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... FireflySci has been manufacturing quartz ... all over the globe. Their cute firefly logo has been spreading to more ... makes spectrophotometer calibration standards that never require recalibration. These revolutionary standards have ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle ... plating options designed to address fractures of the distal tibia and fibula. This ... Acumed Ankle Plating System 3 is composed of seven plate families that span ...
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the ... research that could lead to one good one. Surviving Mesothelioma has just posted an ... The team evaluated 98 mesothelioma patients who got a second kind of ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding ... has granted the company’s orphan drug designation request covering BHV-4157 for the treatment ... by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):